Xencor Inc. is a biopharmaceutical company focused on discovering and developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases, asthma, and allergic diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!